Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-02 Option Award | 2024-12-06 4:32 pm | N/A 2034-12-01 | Aileron Therapeutics Inc. | ALRN | Musso Alan A Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-08-20 Option Award | 2024-08-22 4:05 pm | N/A 2034-08-19 | Aileron Therapeutics Inc. | ALRN | Musso Alan A Director | 2,725 | $0 | 2,725 (Direct) | View |
| 2024-01-26 Option Award | 2024-01-30 9:05 pm | N/A 2034-01-25 | Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-01-17 Option Award | 2024-01-19 4:15 pm | 2024-02-07 2033-08-06 | Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer | 61,822 | $0 | 61,822 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-02 8:53 pm | N/A 2033-10-30 | AILERON THERAPEUTICS INC | ALRN | Musso Alan A Director | 5,450 | $0 | 5,450 (Direct) | View |
Ownership | 2023-11-02 8:51 pm | N/A 2032-05-08 | AILERON THERAPEUTICS INC | ALRN | Musso Alan A Director | 0 | $0 | 17,064 (Direct) | View |
| 2023-08-07 Option Award | 2023-08-09 4:16 pm | N/A 2033-08-06 | Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer | 432,800 | $0 | 432,800 (Direct) | View |
Ownership | 2023-08-09 4:11 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer | 0 | $0 | 0 (Direct) | View |